In 2023, sales of antidepressant medicine in Denmark stood at 25.87 million USD PPP. Forecasted data indicates a steady decline in sales over the next five years, with 2024 projected at 23.85 million USD, followed by continuous decreases each subsequent year: 21.94 million USD in 2025, 20.07 million USD in 2026, 18.23 million USD in 2027, and 16.44 million USD in 2028. Year-on-year variations indicate a consistent downward trend:
- 2024: -7.81%
- 2025: -7.99%
- 2026: -8.52%
- 2027: -9.15%
- 2028: -9.81%
The Compound Annual Growth Rate (CAGR) over the five-year period from 2024 to 2028 is -7.94%.
Future trends to watch for include potential shifts in healthcare policies, increased competition from generic drugs, and advancements in alternative treatments such as psychotherapy and lifestyle interventions. Monitoring these factors will be crucial in understanding future sales dynamics in Denmark's antidepressant market.
